CD33 Splice Site Genotype Was Not Associated With Outcomes of Patients Receiving the Anti-Cd33 Drug Conjugate SGN-CD33A
Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-019-0771-0
Full Text
Open PDFAbstract
Available in full text
Date
August 22, 2019
Authors
Publisher
Springer Science and Business Media LLC